Evidence-Based Therapy for Recurrent Cervical Cancer-Reference-Cited by-同舟云学术

Evidence-Based Therapy for Recurrent Cervical Cancer

Published:2014-09-01 Issue:25 Volume:32 Page:2687-2690
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Monk Bradley J.¹,Tewari Krishnansu S.²

Affiliation:

1. University of Arizona Cancer Center, Creighton University School of Medicine at Dignity Health St Joseph's Hospital and Medical Center, Phoenix, AZ

2. University of California Irvine Medical Center, Orange, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference13 articles.

1. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement

2. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma?

3. Impact of facility volume on therapy and survival for locally advanced cervical cancer

4. Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Hysterectomy in Patients After Radiation for Locally Advanced Cervical Cancer: A Single-Center Prospective Longitudinal Study;The Journal of Obstetrics and Gynecology of India;2024-08

2. Laparoscopic Total Mesorectal Excision With Combined Resection of the Ureter and Ureterovesical Reimplantation for Recurrent Cervical Adenocarcinoma;Diseases of the Colon & Rectum;2024-07-05

3. Re-irradiation for recurrent cervical cancer: A single institutional experience;Clinical and Translational Radiation Oncology;2023-11

4. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway;Journal of Inorganic Biochemistry;2022-10

5. Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience;Frontiers in Oncology;2022-07-19